Biosimilar Testing Services Market Analysis, Demand And Outlook 2025- 2034

Focused on real-world business use, this report highlights what’s changing in the biosimilar testing services market and what companies should prepare for next.

How Fast Is The Biosimilar Testing Services Market Growing Towards 2025?
The biosimilar testing services market size has grown rapidly in recent years. It will grow from $1.62 billion in 2024 to $1.84 billion in 2025 at a compound annual growth rate (CAGR) of 13.3%. The growth in the historic period can be attributed to increasing demand for biologics, expanding approval of biosimilars, increasing prevalence of chronic diseases, increasing demand for personalized medicine, and expansion of clinical trial activities.

The biosimilar testing services market size is expected to see rapid growth in the next few years. It will grow to $2.99 billion in 2029 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to increasing adoption of biosimilars, growing demand for cost-effective treatments, rising demand for affordable biologic therapies, growing trust in biosimilar efficacy and safety, and increasing demand for customized testing solutions. Major trends in the forecast period include advancements in analytical testing technologies, continuous innovations in bioassay development, growing adoption of high-throughput testing platforms, increased research and development in biosimilar analytics, and integration of artificial intelligence in data analysis.

Get your free sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27225&type=smp

Biosimilar Testing Services Market Drivers And Opportunities
The growing prevalence of autoimmune diseases is expected to propel the growth of the biosimilar testing services market going forward. Autoimmune diseases are conditions in which the body's immune system mistakenly attacks its own healthy cells and tissues, leading to inflammation and tissue damage. The growing prevalence of autoimmune diseases is due to the increasing need for effective biologic treatments that can manage chronic symptoms, reduce flare-ups, and improve long-term patient outcomes. Biosimilar testing services support the treatment of autoimmune diseases by ensuring biosimilars are safe, effective, and comparable to original biologics, helping to provide affordable and accessible therapeutic options. For instance, in June 2024, according to the Australian Institute of Health and Welfare, an Australia-based government organization, an estimated 514,000 people (2.0%) in Australia were living with rheumatoid arthritis in 2022, with 2.5% of females and 1.6% of males affected. Therefore, the growing prevalence of autoimmune diseases is driving the growth of the biosimilar testing services market.

How Is The Biosimilar Testing Services Market Segmented?
The biosimilar testing services market covered in this report is segmented

1) By Service Type: Analytical Testing, Bioanalytical Testing, Stability Testing, Method Development And Validation, Other Service Types
2) By Technology: Cell-Based Assays, Chromatography Techniques, Mass Spectrometry, Bioassays
3) By Molecule Type: Monoclonal Antibodies, Recombinant Hormones, Insulin, Interferons, Enzymes, Other Molecule Types
4) By Application: Oncology, Autoimmune Diseases, Blood Disorders, Growth Hormone Deficiency, Other Applications
5) By End User: Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, Government Agencies

Subsegments:
1) By Analytical Testing: Protein Characterization, Impurity Profiling, Potency Testing, Glycosylation Analysis, Structural Analysis
2) By Bioanalytical Testing: Pharmacokinetics Analysis, Immunogenicity Testing, Biomarker Analysis, Drug Concentration Measurement, Toxicokinetics Testing
3) By Stability Testing: Long-Term Stability Testing, Accelerated Stability Testing, Stress Testing, Photostability Testing, Temperature Cycling Studies
4) By Method Development And Validation: Analytical Method Development, Bioanalytical Method Development, Method Validation, Process Validation, Assay Development
5) By Other Service Types: Immunogenicity Assessment, Formulation Development, Microbial Testing, Release Testing, Regulatory Consulting

What Are The Future Trends Of The Biosimilar Testing Services Market?
Major companies operating in the biosimilar testing services market are focusing on expanding facilities to introduce new technologies or capabilities that enhance productivity and competitiveness. Facility expansion is the process of enlarging or upgrading an existing physical space or infrastructure to accommodate increased operational needs or future growth. For instance, in October 2023, Tanvex BioPharma USA Inc., a US-based biotechnology company, launched Tanvex CDMO, a state-of-the-art contract development and manufacturing organization located in San Diego, offering end-to-end biologics development and manufacturing services, including cell line development, process optimization, analytical testing, and regulatory support. This new facility aims to accelerate the advancement of biopharmaceutical products from concept to commercial scale, leveraging cutting-edge technologies and experienced teams to deliver innovative and life-changing biologics to patients worldwide.

Major Companies Operating In The Biosimilar Testing Services Market Are:
Major companies operating in the biosimilar testing services market are Thermo Fisher Scientific Inc., IQVIA Laboratories, Laboratory Corporation of America Holdings, Fresenius SE & Co. KGaA, Eurofins Scientific SE, Intas Pharmaceuticals Ltd., SGS Société Générale de Surveillance SA, WuXi AppTec Co. Ltd., Intertek Group plc, Samsung Biologics Co. Ltd., Celltrion Inc., Almac Group Limited, Syngene International Limited, Shanghai Medicilon Inc., Kymos Group S.L., Pacific BioLabs Inc., Profacgen Inc., ExcellGene SA, BioPharmaSpec Ltd., and Sartorius Stedim Biotech Group.

View the full biosimilar testing services market report here:
https://www.thebusinessresearchcompany.com/report/biosimilar-testing-services-global-market-report

Regional Analysis: Opportunities And Challenges In The Biosimilar Testing Services Market
North America was the largest region in the biosimilar testing services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biosimilar testing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company